Cost‐effectiveness of risk‐based breast cancer screening: a systematic review

SA Khan, KV Hernandez‐Villafuerte… - … journal of cancer, 2021 - Wiley Online Library
To analyse published evidence on the economic evaluation of risk‐based screening (RBS),
a full systematic literature review was conducted. After a quality appraisal, we compared the …

Methods, Detection Rates, and Survival Outcomes of Screening for Head and Neck Cancers: A Systematic Review

EA Sykes, N Weisbrod, E Rival, A Haque… - … –Head & Neck …, 2023 - jamanetwork.com
Importance Head and neck cancers (HNCs) are often diagnosed at advanced clinical stages
during their symptomatic phase, leading to a reduced treatment window and poor survival …

Injectable corilagin/low molecular weight chitosan/PLGA-PEG-PLGA thermosensitive hydrogels for localized cancer therapy and promoting drug infiltration by …

X Jin, Q Fu, Z Gu, Z Zhang, H Lv - International Journal of Pharmaceutics, 2020 - Elsevier
The stroma in solid tumors severely impedes drug delivery via systemic administration to
cancer cells, especially when using nano-drug delivery systems. Therefore, we developed …

Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer

J Xie, SN Li, YM Li, JH Li - BMC Health Services Research, 2023 - Springer
Background The effectiveness of sacituzumab govitecan for metastatic triple-negative breast
cancer (TNBC) has been reported in recent research, however, the value of the …

Association between primary care use prior to cancer diagnosis and subsequent cancer mortality in the Veterans Affairs Health System

EM Qiao, K Guram, NV Kotha, RS Voora… - JAMA Network …, 2022 - jamanetwork.com
Importance Primary care physicians (PCPs) are significant contributors of early cancer
detection, yet few studies have investigated whether consistent primary care translates to …

[HTML][HTML] Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program …

AM Chiarelli, MJ Walker… - … Open Access Journal, 2021 - cmajopen.ca
Background: Breast cancer screening in Ontario, Canada, was deferred during the first wave
of the COVID-19 pandemic, and a prioritization framework to resume services according to …

Uptake rates of risk-reducing surgeries for women at increased risk of hereditary breast and ovarian Cancer applied to cost-effectiveness analyses: A scoping …

J Simões Corrêa Galendi, S Kautz-Freimuth, S Stock… - Cancers, 2022 - mdpi.com
Simple Summary For women who have tested positive for BRCA mutations, the decision to
make use of preventive surgical options, such as risk-reducing mastectomy (RRM) or risk …

Cost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future?

JP Bewersdorf, SF Huntington, AM Zeidan - Journal of the National …, 2023 - jnccn.org
Acute myeloid leukemia (AML) is the most common acute leukemia in adults in the United
States and has seen the approval of several novel agents over the past decade. Similar to …

Costs and effects of implementing digital tomosynthesis in a population-based breast cancer screening program: predictions using results from the To-Be Trial in …

TA Moger, Å Holen, B Hanestad, S Hofvind - PharmacoEconomics-Open, 2022 - Springer
Background Although several studies from Europe and the US have shown promising
screening results favoring digital breast tomosynthesis compared with standard digital …

The Lancet Breast Cancer Commission

CE Coles, H Earl, BO Anderson, CH Barrios, M Bienz… - The Lancet, 2024 - thelancet.com
Executive summary The Lancet Breast Cancer Commission—a diverse, multidisciplinary
international group—are unanimous in our determination to improve the lives of all people …